![]() |
|
|
Vol. 30, Issue 5, 576-581, May 2002
Department of Cell and Molecular Pharmacology and Experimental
Therapeutics, Medical University of South Carolina, Charleston, South
Carolina (Y.O., T.W.); and Amgen Inc., Thousands Oaks, California
(F.H.)
In a previous study, we used human liver microsomes for the first
time to study cytochrome P450 (P450)-mediated oxidation of the
flavonoid galangin. The combination of CYP1A2 and CYP2C9 produced a
Vmax/Km value of
13.6 ± 1.1 µl/min/mg of protein. In the present extended study,
we determined glucuronidation rates for galangin with the same
microsomes. Two major and one minor glucuronide were identified by
liquid chromatography/mass spectrometry. The
Vmax/Km values
for the two major glucuronides conjugated in the 7- and 3-positions
were 155 ± 30 and 427 ± 26 µl/min/mg of protein, thus,
exceeding that of oxidation by 11 and 31 times, respectively. This
highly efficient glucuronidation appeared to be catalyzed mainly by the
UDP-glucuronosyltransferase (UGT)1A9 isoform but also by UGT1A1 and
UGT2B15. Sulfation of galangin by the human liver cytosol, mediated
mainly but not exclusively by sulfotransferase (SULT) 1A1, also
appeared to be efficient. These conclusions were strongly supported by
experiments using the S9 fraction of the human liver, in which all
three metabolic pathways could be directly compared. When galangin
metabolism was examined in fresh plated hepatocytes from six donors,
glucuronidation clearly predominated followed by sulfation. Oxidation
occurred only to a minor extent in two of the donors. This study for
the first time establishes that glucuronidation and sulfation of
galangin, and maybe other flavonoids, are more efficient than
P450-mediated oxidation, clearly being the metabolic pathways of choice
in intact cells and therefore likely also in vivo.
This article has been cited by other articles:
![]() |
J. Guo, A. Liu, H. Cao, Y. Luo, J. M. Pezzuto, and R. B. van Breemen Biotransformation of the Chemopreventive Agent 2',4',4-Trihydroxychalcone (Isoliquiritigenin) by UDP-Glucuronosyltransferases Drug Metab. Dispos., October 1, 2008; 36(10): 2104 - 2112. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. K. Walle and T. Walle Bioavailable Flavonoids: Cytochrome P450-Mediated Metabolism of Methoxyflavones Drug Metab. Dispos., November 1, 2007; 35(11): 1985 - 1989. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wen and T. Walle Methylated Flavonoids Have Greatly Improved Intestinal Absorption and Metabolic Stability Drug Metab. Dispos., October 1, 2006; 34(10): 1786 - 1792. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Turgeon, J.-S. Carrier, S. Chouinard, and A. Belanger Glucuronidation Activity of the UGT2B17 Enzyme toward Xenobiotics Drug Metab. Dispos., May 1, 2003; 31(5): 670 - 676. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lu, X. Meng, C. Li, S. Sang, C. Patten, S. Sheng, J. Hong, N. Bai, B. Winnik, C.-T. Ho, et al. Glucuronides of Tea Catechins: Enzymology of Biosynthesis and Biological Activities Drug Metab. Dispos., April 1, 2003; 31(4): 452 - 461. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Vaidyanathan and T. Walle Glucuronidation and Sulfation of the Tea Flavonoid (-)-Epicatechin by the Human and Rat Enzymes Drug Metab. Dispos., August 1, 2002; 30(8): 897 - 903. [Abstract] [Full Text] [PDF] |
||||